NO123610B - - Google Patents

Download PDF

Info

Publication number
NO123610B
NO123610B NO5064/69A NO506469A NO123610B NO 123610 B NO123610 B NO 123610B NO 5064/69 A NO5064/69 A NO 5064/69A NO 506469 A NO506469 A NO 506469A NO 123610 B NO123610 B NO 123610B
Authority
NO
Norway
Prior art keywords
pyrimidinyl
lower alkyl
formula
imidazolium
alkyl
Prior art date
Application number
NO5064/69A
Other languages
English (en)
Norwegian (no)
Inventor
J Bicking
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO123610B publication Critical patent/NO123610B/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO5064/69A 1968-12-23 1969-12-22 NO123610B (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78636968A 1968-12-23 1968-12-23

Publications (1)

Publication Number Publication Date
NO123610B true NO123610B (cg-RX-API-DMAC7.html) 1971-12-20

Family

ID=25138387

Family Applications (1)

Application Number Title Priority Date Filing Date
NO5064/69A NO123610B (cg-RX-API-DMAC7.html) 1968-12-23 1969-12-22

Country Status (13)

Country Link
US (1) US3557114A (cg-RX-API-DMAC7.html)
BE (1) BE743510A (cg-RX-API-DMAC7.html)
BR (1) BR6914814D0 (cg-RX-API-DMAC7.html)
CH (1) CH522660A (cg-RX-API-DMAC7.html)
DE (1) DE1964282A1 (cg-RX-API-DMAC7.html)
ES (1) ES374692A1 (cg-RX-API-DMAC7.html)
FR (1) FR2026902B1 (cg-RX-API-DMAC7.html)
GB (1) GB1252847A (cg-RX-API-DMAC7.html)
IL (1) IL33538A (cg-RX-API-DMAC7.html)
NL (1) NL6918402A (cg-RX-API-DMAC7.html)
NO (1) NO123610B (cg-RX-API-DMAC7.html)
SE (1) SE353722B (cg-RX-API-DMAC7.html)
ZA (1) ZA698862B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE43313B1 (en) 1975-09-03 1981-01-28 Pfizer Quaternary salts as hypoglycemic agents
EP0421266A1 (de) * 1989-10-06 1991-04-10 BASF Aktiengesellschaft Azolylpyrimidin- und -triazinderivate und sie enthaltende Mittel
US5916891A (en) 1992-01-13 1999-06-29 Smithkline Beecham Corporation Pyrimidinyl imidazoles
ZA9610687B (en) * 1995-12-22 1997-09-29 Smithkline Beecham Corp Novel synthesis.
AP9700912A0 (en) 1996-01-11 1997-01-31 Smithkline Beecham Corp Novel cycloalkyl substituted imidazoles
US5756499A (en) * 1996-01-11 1998-05-26 Smithkline Beecham Corporation Substituted imidazole compounds
US6046208A (en) * 1996-01-11 2000-04-04 Smithkline Beecham Corporation Substituted imidazole compounds
US5929076A (en) * 1997-01-10 1999-07-27 Smithkline Beecham Corporation Cycloalkyl substituted imidazoles
US6239279B1 (en) * 1998-12-16 2001-05-29 Smithkline Beecham Corporation Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives

Also Published As

Publication number Publication date
SE353722B (cg-RX-API-DMAC7.html) 1973-02-12
ZA698862B (en) 1971-07-28
BR6914814D0 (pt) 1973-03-08
CH522660A (de) 1972-06-30
NL6918402A (cg-RX-API-DMAC7.html) 1970-06-25
DE1964282A1 (de) 1970-07-09
IL33538A0 (en) 1970-02-19
ES374692A1 (es) 1972-01-01
FR2026902A1 (cg-RX-API-DMAC7.html) 1970-09-25
FR2026902B1 (cg-RX-API-DMAC7.html) 1973-08-10
BE743510A (cg-RX-API-DMAC7.html) 1970-06-22
US3557114A (en) 1971-01-19
GB1252847A (cg-RX-API-DMAC7.html) 1971-11-10
IL33538A (en) 1972-08-30

Similar Documents

Publication Publication Date Title
EP2651918B1 (en) Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine
US3586695A (en) Substituted imidazolinyl indoles
DE3023369A1 (de) Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4086353A (en) Certain azolinylamino (azolidinylimino) indazoles
EP3348547A1 (en) Novel benzimidazole compound and pharmaceutical use of same
NO309936B1 (no) 2,7-Substituerte oktahydro-pyrrol[1,2-a]pyrazin-derivater, anvendelse derav, farmasøytisk preparat, samt mellomprodukter for fremstilling av derivatene
TW201704226A (zh) 吡啶取代的2-氨基吡啶類蛋白激酶抑制劑的結晶
US4036976A (en) Substituted imidazolinylamino-indazoles
US3557114A (en) 1-substituted-3-(2-pyrimidinyl) imidazolium salts
WO2019134573A1 (zh) 一种氘代二苯氨基嘧啶类化合物的制备方法及其晶型
HU190653B (en) Process for preparing new triazolo-pyrimidine derivatives
EP1935883A1 (en) Oxindole derivative as feeding control agent
RU2261862C2 (ru) Замещенные пирролы
CN113248474A (zh) 五元氮唑杂环衍生物及其制备方法和用途
EP1966192B1 (en) Pyrimidine derivatives for the treatment of abnormal cell growth
US3002001A (en) 4-alkylimino-1-[aromatic-(lower - alkyl)]-1,4-dihydroquinolines and their preparation
EP4105217A1 (en) 3-((8-((1h-pyrazol-4-yl)amino)imidazo[1,2-a]pyridin-3-yl)ethinyl)-n-phenylbenzamide derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancer
CN108276415B (zh) 一种烷氧化三唑并四嗪类化合物及其制备方法和应用
EP0000151B1 (en) 1-substituted aminoindolines, process for their production and pharmaceutical compositions containing them
NO161102B (no) Lokkemat for gnagere omfattende foede og en gift.
Zunszain et al. Tritylamino Aromatic Heterocycles and Related Carbinols as Blockers of Ca 2+‐Activated Potassium Ion Channels Underlying Neuronal Hyperpolarization
US3635962A (en) 4 - bis-morpholino- and 2
TW201908320A (zh) 一種btk激酶抑制劑的結晶形式及製備方法
JPS6223723B2 (cg-RX-API-DMAC7.html)
CN119874676A (zh) 一种pi3k抑制剂及其制备方法和用途